Array BioPharma, Inc. has appointed April H. Teitelbaum, M.D., MS, FACP, to the newly created position of vice president of clinical development, oncology. Dr. Teitelbaum will oversee the medical strategy and clinical development of the company’s oncology drug pipeline and will report to the company’s chief executive officer, Robert E. Conway. “April’s solid track record and experience in developing new cancer drugs will be invaluable to Array as we advance our exten...